Literature DB >> 1202082

Erythropoietic protoporphyria and lead intoxication: the molecular basis for difference in cutaneous photosensitivity. I. Different rates of disappearance of protoporphyrin from the erythrocytes, both in vivo and in vitro.

S Piomelli, A A Lamola, M F Poh-Fitzpatrick, C Seaman, L C Harber.   

Abstract

In lead intoxication photosensitivity is usually absent, despite concentrations of protoporphyrin in the erythrocytes equal to or greater than in erythropoietic protoporphyria. Profound differences in the distribution of protoporphyrin in aging erythrocytes were demonstrated by age-dependent fractionation of cells on discontinuous density gradients. In erythropoietic protoporphyria the concentration of protoporphyrin declined extremely rapidly with erythrocyte age; the bulk of the protoporphyrin was lost in less than 3 days and the concentration of fluorescent erythrocytes in the gradient paralleled the decline of protoporphyrin. In lead intoxication the protoporphyrin concentration declined only slightly with cell aging and erythrocytes of all ages fluoresced. In the bone marrow from a patient with erythropoietic protoporphyria all reticulocytes, but only occasional late normoblasts, fluoresced, suggesting a single population. Sterile incubation in plasma (pH 7.5) demonstrated rapid diffusion of protoporphyrin from the erythrocytes in erythropoietic protoporphyria, but not in lead intoxication. Plasma protoporphyrin was elevated in erythropoietic protoporphyria, but not in lead intoxication. Estimates of the daily loss of protoporphyrin from erythropoietic tissue in erythropoietic proporphyria suggested an order of magnitude similar to the total blood protoporphyrin. Therefore, it is not necessary to postulate a preponderant extraerythropoietic source to explain the amount of fecal excretion. A significant amount of the diffused protoporphyrin probably reaches the skin with resulting photosensitivity. In contrast, in lead intoxication protoporphyrin remains within the erythrocyte throughout its life span ; there is no diffusion into the plasma and hence no photosensitivity.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1202082      PMCID: PMC333130          DOI: 10.1172/JCI108233

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  Standardization of hemoglobinometry. II. The hemiglobincyanide method.

Authors:  E van KAMPEN; W G ZIJLSTRA
Journal:  Clin Chim Acta       Date:  1961-07       Impact factor: 3.786

2.  A modification of the benzidine method for measurement of hemoglobin in plasma and urine.

Authors:  W H CROSBY; F W FURTH
Journal:  Blood       Date:  1956-04       Impact factor: 22.113

3.  Separation of erythrocytes according to age on a simplified density gradient.

Authors:  L M Corash; S Piomelli; H C Chen; C Seaman; E Gross
Journal:  J Lab Clin Med       Date:  1974-07

4.  A micromethod for free erythrocyte porphyrins: the FEP test.

Authors:  S Piomelli
Journal:  J Lab Clin Med       Date:  1973-06

5.  Erythrocyte protoporphyrin.

Authors:  E E Langer; R G Haining; R F Labbe; P Jacobs; E F Crosby; C A Finch
Journal:  Blood       Date:  1972-07       Impact factor: 22.113

6.  Medical aspects of childhood lead poisoning.

Authors: 
Journal:  Pediatrics       Date:  1971-09       Impact factor: 7.124

7.  In vivo lability of glucose-6-phosphate dehydrogenase in GdA- and GdMediterranean deficiency.

Authors:  S Piomelli; L M Corash; D D Davenport; J Miraglia; E L Amorosi
Journal:  J Clin Invest       Date:  1968-04       Impact factor: 14.808

8.  Protoporphyrin-induced photohemolysis in protoporphyria and in normal red blood cells.

Authors:  A A Schothorst; J Van Steveninck; L N Went; D Suurmond
Journal:  Clin Chim Acta       Date:  1970-04       Impact factor: 3.786

9.  Iodine tungsten fluorescence microscopy for porphyrin fluorescence. A study on erythropoietic protoporphyria.

Authors:  D J Cripps; R S Hawgood; I A Magnus
Journal:  Arch Dermatol       Date:  1966-01

10.  Erythropoietic protoporphyria: evidence for multiple sites of excess protoporphyrin formation.

Authors:  P Scholnick; H S Marver; R Schmid
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808

View more
  18 in total

1.  Erythropoietic protoporphyria and lead intoxication: the molecular basis for difference in cutaneous photosensitivity. II. Different binding of erythrocyte protoporphyrin to hemoglobin.

Authors:  A A Lamola; S Piomelli; M G Poh-Fitzpatrick; T Yamane; L C Harber
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

2.  Comparative study of protoporphyrins in erythropoietic protoporphyria and griseofulvin-induced murine protoporphyria. Binding affinities, distribution, and fluorescence spectra in various blood fractions.

Authors:  M B Poh-Fitzpatrick; A A Lamola
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

3.  Study of factors causing excess protoporphyrin accumulation in cultured skin fibroblasts from patients with protoporphyria.

Authors:  J R Bloomer; D A Brenner; M J Mahoney
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

Review 4.  Heme biosynthesis and the porphyrias.

Authors:  John D Phillips
Journal:  Mol Genet Metab       Date:  2019-04-22       Impact factor: 4.797

5.  Pitfalls in Erythrocyte Protoporphyrin Measurement for Diagnosis and Monitoring of Protoporphyrias.

Authors:  Eric W Gou; Manisha Balwani; D Montgomery Bissell; Joseph R Bloomer; Herbert L Bonkovsky; Robert J Desnick; Hetanshi Naik; John D Phillips; Ashwani K Singal; Bruce Wang; Sioban Keel; Karl E Anderson
Journal:  Clin Chem       Date:  2015-10-19       Impact factor: 8.327

6.  Behavioral indicators of lead neurotoxicity: results of a clinical field survey.

Authors:  J A Valciukas; R Lilis; J Eisinger; W E Blumberg; A Fischbein; I J Selikoff
Journal:  Int Arch Occup Environ Health       Date:  1978-07-14       Impact factor: 3.015

7.  Patient-recorded outcome to assess therapeutic efficacy in protoporphyria-induced dermal phototoxicity: a proposal.

Authors:  Elisabeth I Minder; Xiaoye Schneider-Yin; Christoph E Minder
Journal:  Health Qual Life Outcomes       Date:  2010-06-21       Impact factor: 3.186

8.  The relationship between zinc protoporphyrin (ZPP) and "free" erythrocyte protoporphyrin (FEP) in lead-exposed individuals.

Authors:  V Karacić; D Prpić-Majić; S Telisman
Journal:  Int Arch Occup Environ Health       Date:  1980       Impact factor: 3.015

Review 9.  Erythroid heme biosynthesis and its disorders.

Authors:  Harry A Dailey; Peter N Meissner
Journal:  Cold Spring Harb Perspect Med       Date:  2013-04-01       Impact factor: 6.915

10.  Protoporphyrin hepatopathy. Effects of cholic acid ingestion in murine griseofulvin-induced protoporphyria.

Authors:  M B Poh-Fitzpatrick; J A Sklar; C Goldsman; J H Lefkowitch
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.